he is retiring from novo nordisk to start a career with the novo nordisk foundation. him will focus on research and early development and the other focusing on product of elements. that means we will have even more focus, in my executive team, on r&d. the platform for growth for the coming -- that is a continuous execution of our existing strategies, and it is really two people who have delivered a lot of the growth in the past, and success in r&d. francine: thank you so much, lars fruergaard, the chief executive of novo nordisk. coming up, as northern ireland's border gets dragged into a europe-wide row, we speak to the ambassador of the u.k. that is coming up next, and this is bloomberg. ♪ francine: economics, finance, politics. this is "bloomberg surveillance." i'm francine lacqua, here in london. it is a little more than a month since the u.k. left this single market and customs union, but already relations are being tested. michael gove's desk -- demanding that the european union own -- amid rising tensions in the region. also over the last week, the you threaten

according to novo artist one and a half years after treatment 40 percent of patients like me. still have cancer. that's a start but could it be better. of course but the drug i'm currently on had a 20 percent chance of success. in the south was good there were days when i thought that's it as he gets older. i could only hope my final hours would go quickly told us this done i didn't want my family to have to watch forever and for me to be a never ending with a work out committee and i didn't want to lie around like a vegetable on drugs all strogatz with the roots to cook music in the dog. about a dozen cancer patients cannot be treated due to the price dispute critics might claim the health insurers are at fault with terminally ill patients running out of time and dying while negotiations my gone with navarre to see the fall of the euro or there's this level of neither thought of it but that's not the case we all share the responsibility because we have yet to find a solution to this all around less than ideal situation follett it's not so. mikhail monch times family has scrap

a couple of lines coming across the bloomberg now on novo nordisk. all about share buybacks for this company. they are starting a share buyback program. i lost my page. that was a schoolboy error. if you can pick it up, i think we have a share buyback in the mix. first quarter profits, 9.3 2 billion. give me the dividend, save me. annmarie: don't worry, we are going too of novo nordisk coming up, he can answer all those questions. you don't want to miss that conversation. they pretty much came in line in terms of estimates. let's get a recap of your first word news. >> european commission president ursula von der leyen is taking responsibility for the vaccine roll up. -- rollout. russia has jailed opposition leader alexey navalny for two years and eight months. he was arrested last month for his return from germany where he had been recovering from a near fatal nerve agent attack. in a statement to the court, he said someone did not want him to return to russia a free man, referring to president putin. the legal team of former president donald trump

here's my last hope is a gene therapy with cancer killing cells such as kim mariah from novo artists with a price tag of 370000 swiss francs and camera is just the beginning a new drug let's turn it was injected into it on $850000.00 gens but it's now the most expensive drug on earth right. $1000000000.00 how willing a society to bear the costs of withholding or do let someone die to save money or power at these prices calculated valmont do it southwest of the coals pharmaceutical companies sound the market to determine what can they get out of it and will limit ceaselessly meet the. board health insurance companies pay these record prices. 55370000 francs is a lot of money and we can't afford it was what can you do. it's tricky it's hard to tell what the future has in store. we're going to get this cancer. let's hope so. michela and has a rare and aggressive form of lymph node cancer his crooked mouth also comes from the disease. his last hope is kim riaa a completely new treatment just approved last fall. samples are taken of the patient's own immune cells and these are sent to a n

fair price current of $200000.00 or infusion in 2019 using the assumptions using the assumption that novo artists were generated total of $1700.00 patients and fusions out of 14. out of 14000 potentially. goes on we can actually drop that price it can be reduced to about half of 370000 francs the fair price is calculated in such a way that no bar to sit cheats an average operating profit of 20.7 percent the research costs averaging at 17.3 percent are also included in this calculation the health insurer associates. sometimes there's also demanding a price of 200000 francs for him right. i've looked at the document you send me a document is full of incorrect information thank you for the correct information i cannot give you that and i am up i cannot comment on it because it is not ardent da our data is not our document the criticism on the farm are not just not artists but on the farmers in transparency it's growing worldwide we hear it we age o.b. hear it with the health insurers with the public because the public is the payer. are you afraid that this will damage the image of nobodies.

his my last hope is a gene therapy with cancer killing cells such as kim mariah from novo artists with a price tag of 370000 swiss francs and camera is just the beginning of a new drug let's turn it was injected into with $850000.00 gens but it's now the most expensive drug on earth right. $1000000000.00 how willing a society to bear the costs it would hold in order to let someone die to save money because their. power at these prices calculated. of course pharmaceutical companies sound the market to determine what can make it health of it and with. the full model. would health insurance companies pay these record prices. 437-0000 francs that's a lot of money and we can't afford it what can you do. it's tricky it's hard to tell what the future has in store. we're going to get this cancer. let's hope so. mikhail dion has a rare and aggressive form of lymph node cancer his crooked mouth also comes from the disease. his last hope is camera a completely new treatment just approved last fall. samples are taken of the patient's own immune cells and these are sent to a noble artist laboratory

this is a de novo hearing, and it's up to the board. i'd like to get your feedback on that aspect of the project. the second aspect before the board is about that relationship and the fire wall, and if the stairs need to move, can they remain where they are with some changes? we really need the board's help to unpack some of these issues because it's not going to end here. we still need a building permit. >> president honda: this is like 46 duncan. >> it is, and in that case, the devil is in the small details. >> operator: that's time. >> thank you. >> clerk: thank you. we have a question from commissioner swig and then commissioner lazarus. >> commissioner swig: so great segue on the 46 duncan mention because i was going to ask, what do we do now in asking for your advice, scott, but we determined on 46 duncan, if you build it, it might not stay because it was not legal, and so in this case, you have a -- in fact, in this case, i think the intrusion on the next-door neighbor is significantly more serious than it was on 46 duncan, but t

this question is well do you worry that the coronavirus vaccine crisis in europe will spill doom for novo needs hopes for help because the russians now have a coronavirus back seem to offer. i know it sounds funny you know like that i listen but scenes and of course this would think we've seen is not. a thing that can be seen as effect of trade between no west and russia. yeah the west the reaction is very very important and we see that this reaction is pretty tough mccrone met killer biden all of them will have a very tough stand here but i don't think that wasn't putin now with thinks about 4 of the dacian up to war ukraine up to poison it not lining up to change because to do so he has no reputation abroad so he only it worries about brought us inside becomes so it's of course it's good that that's not all the regime and countries are united in one position against the serious the violent against. authoritarian trends in russia but still i think this is not enough even sanction if sanctions will be very tough if there will be no north 3 if there will be no no no no sweet i mean this ba

his motto is a gene therapy with cancer killing cells such as kim mariah from novo artists with a price tag of $370000.00 swiss francs and camera is just the beginning a new drug let's turn it was injected into on $850000.00 gens but it's now the most expensive drug on earth the price tag of $1000000.00 was how willing a society to bear the costs of loophole when you let someone die to save money or power at these prices calculated paul. scholes pharmaceutical companies sell the market to determine what can make it a house of it and with a limousine you need the. would health insurance companies pay these record prices . 437-0000 francs that's a lot of money and we can't afford it what can you do. it's tricky it's hard to tell what the future has in store. all you want we're going to get this cancer. out of let's hope so. mikhail dion has a rare and aggressive form of lymph node cancer his crooked mouth also comes from the disease. his last hope is camera a completely new treatment just approved last fall. the samples are taken of the patient's own immune cells and these are sent to a n

we had santander, siemens, novo nordisk, all the really good numbers as well, but if you look at whats actually going on in the u.s., the numbers so far are much better than everyone expected, but to be honest, a good number is already priced into the market. if you look at q4 earnings, we will be down 2%. revenue numbers will be up 2%. earnings beats have been really good but the market sold into the earnings beats. if you look at the 2020 numbers, it's been a bad year, manus. -12% for earnings. -1% for revenues. it's a pickup that everyone is focused on. if you go into 2021, you look at analyst forecasts, you are expecting 24% growth in earnings on a much lower base but the key number we are really focused on is the revenue number which is up around 90%. you talked about a few -- attack trade still looks very crowded. we are buying on the dip but it's hard to get excited with valuations where they are at the moment. everybody is focused on cloud computing, yes she's have now become very topical as well. we have become more constructive on health care in u.s. financials, trading, and

mark novo. always a pleasure to have you on ah, mark. let's talk more about this partnership. explain a little bit more about what fema in particular will handle at this site. good afternoon heather holmes similar to disasters work. fema is a coordinating agency. the president has tapped fema to come in and coordinate the different agencies particular to the vaccine site. in particular, they're using the department of defense. nurses and doctors. army corps of engineers, health and human services, and so fema is there to coordinate, but they've also spread the responsibility as to who's doing what, for instance, fema will handle security. ambulances and emergency medical technicians, equipment supplies, vaccines, medical supplies, and i t the state's requested to handle security in partnership with federal government. a site location i t systems and i t training and the department of defense will handle vaccinators vaccine prepares medical screeners, nurses pharmacy, etcetera, so it is a great partnership going on across all levels of government. it certainly is and as you. in